<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04179747</url>
  </required_header>
  <id_info>
    <org_study_id>0925-0585</org_study_id>
    <nct_id>NCT04179747</nct_id>
  </id_info>
  <brief_title>Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study</brief_title>
  <official_title>A Comparison of Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Islamic University, Islamabad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>International Islamic University, Islamabad</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy
      to individuals suffering from erectile dysfunction. The study was randomized controlled trial
      with two arms involving a control group. The study was conducted with an aim of pilot and
      feasibility study to evaluate the efficacy and suitability of cognitive behavior
      psychotherapy with individuals suffering from erectile dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 18, 2018</start_date>
  <completion_date type="Actual">July 24, 2018</completion_date>
  <primary_completion_date type="Actual">July 24, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Index of Erectile Functioning-5</measure>
    <time_frame>3 months maximum</time_frame>
    <description>The minimum scale score is 5. The maximum scale score is 25. The higher score indicates better erectile functioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression, Anxiety, and Stress Scale-21</measure>
    <time_frame>3 months maximum</time_frame>
    <description>The scale has three sub-scales.
Depression sub scale, Minimum Score: Zero; Maximum Score: 42
Anxiety sub scale, Minimum Score: Zero; Maximum Score: 42
Stress sub scale, Minimum Score: Zero; Maximum Score: 42 The lowest scores on each of the sub scales indicate better functioning, the higher scores on each sub scale indicate a worse outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The cognitive behavior psychotherapy was administered to participants in this treatment arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group received the administration of pharmacotherapy (PDE5i) for treatment of Erectile Dysfunction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Psychotherapy</intervention_name>
    <description>The Cognitive Behavior Psychotherapy was provided for a period of maximum 3 months.</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>Cognitive Behavior Psychotherapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil Citrate 50Mg Tab</intervention_name>
    <description>The participants in control group arm received Sildenafil Citrate 50mg tablet on demand for a period of maximum 3 months.</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>PDE5i</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men diagnosed with erectile dysfunction

          2. Must be in the age range of 18 to 39 years

          3. Must be in a stable heterosexual relationship

          4. Must not be suffering from any medical or psychiatric illness

        Exclusion Criteria:

          1. Men not meeting criteria of diagnosis of erectile dysfunction

          2. Men not in a heterosexual relationship

          3. Men of or above the age of 40 years

          4. Men diagnosed with any medical or psychiatric illness or obese men
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmad Bilal, MPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Islamic University, Islamabad, Pakistan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ahmad Bilal Private Practice</name>
      <address>
        <city>BahƒÅwalpur</city>
        <state>South Punjab</state>
        <zip>63100</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 24, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2019</study_first_posted>
  <last_update_submitted>November 26, 2019</last_update_submitted>
  <last_update_submitted_qc>November 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>International Islamic University, Islamabad</investigator_affiliation>
    <investigator_full_name>Ahmad Bilal</investigator_full_name>
    <investigator_title>Principal Investigator, PhD Research Candidate</investigator_title>
  </responsible_party>
  <keyword>Sexual Dysfunctions, Men Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

